RéSUMé
Un consensus existe au sujet d’une relation stricte entre reflux gastro-œsophagien (RGO), œsophagite et endobrachyœsophage (EBO). Bien que le RGO soit une des pathologies gastroentcrologiques les plus fréquentes, de nombreux facteurs inconnus semblent responsables du développement de ????, qui survient chez une minorité de malades [7 à 23 %]. D’après les données relatives à la prévalence dans la population générale, basées sur les rapports d’autopsie, il semble que la majorité des cas de RGO demeurent non diagnostiqués tout au long de leur vie.
Les hypothèses avancées sur les facteurs en cause concernent le reflux alcalin ou le niveau œsophagien atteint par le liquide reflué. Des études ultérieures sont nécessaires pour parvenir à une compréhension plus satisfaisante de la relation entre œsophagite et EBO, ainsi que l’impact du traitement anti-reflux médical et chirurgical sur la progression de la maladie. La surveillance périodique des formes les plus sévères du RGO et de l’œsophagite semble la plus appropriée, compte tenu de l’incidence élevée de l’??? chez ces patients (16 à 23 %).
Summary
There is general agreement that a strict relationship exists between gastroesophageal reflux disease (GERD), esophagitis, and Barrett’s esophagus (BE). Being GERD one of the most frequent gastroenterological condition, still unknown factors are responsible for the development of BE, which occurs only in a minority of patients (7 to 23 %). From prevalence data in general population inferred from autopsy report, it seems that the majority of cases of BE remain undiagnosed during lifetime.
Hypotheses are advanced on the relevance of factors such as alcaline reflux, or the intraesophageal level of reflux. At the present time, there is need for further studies in order to achieve a more satisfactory understanding of the relationship between esophagitis and BE, and the impact of surgical and medical antireflux therapy on the progression of the disease. Periodic surveillance of the more severe forms of GERD and esophagitis seems to be appropriate because of the quite high incidence of BE (16 to 23 %) in these patients.
RéFéRENCES
ATTWOOD S.E.A., DE MEESTER T.R., BREMNER C.G., BARLOW A.P., HINDER R.A. - Alkaline gas- troesofageal reflux: implications in the development of complications in Barrett’columnar-lined lower esophagus.Surgery, 1989,106, 764–770.
BALDI F., CORINALDESI R., FERRARINI F., STAN-GHELLINI V., MIGLIOLI M., BARBARA L. - Gastric secretion and emptying of liquids in reflux esophagitis.Dig. Dis. Sci., 1981,97, 886–889.
BORRIE G., GOLDWATER L. - Columnar cell lined esophagus: Assesment of etiology and treatment : A 22 years experience.J. Thorac. Cardiovasc. Surg., 1976,71, 825–834.
BROSSARD E., OLLYO J.B., MONNIER P.H. et al. - Columnar-type epithelium (Barrett’s epithelium) develops after healing in 18 % of adults with erosive of ulcerative reflux esophagitis. Gaslroenterology, 1991, 100, A36 (Abstract).
BURBIGE E.J., RADIGAN J.J. - Characteristics of the columnar-cell lined (Barrett’s) esophagus.Gastrointest. Endosc, 1979,25, 133–136.
BURNS T.W., VENTURATOS S.G. - Esophageal motor function and response to acid perfusion in patients with symptomatic reflux esophagitis.Dig. Dis. Sci., 1985,30, 529–535.
CAMERON A.J., PAYNE W.S. - Barrett’s esophagus occurring as a complication of scleroderma.Mayo Clin. Proc, 1978,53, 612–615.
CAMERON A.J., ZINSMEISTER AR., BALLARD D.J., CARNEY J.A. - Prevalence of columnar lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings.Gastroenterology, 1990,99, 918–922.
COOPER B.T., BARBEZAT G.O. - Barrett’s esophagus: a clinical study of 52 patients.Q. J. Med., 1987,62, 97–108.
DEMEESTER T.R., ATTWOOD S.E., SMYRK T.C. etal. - Surgical therapy in Barrett’s esophagus.Ann. Surg., 1990,212, 528–540.
DODDS W.J., HOGAN W.J., HELM J.F. and DENT J. - Pathogenesis of reflux esophagitis.Gastroenterology, 1981,87, 376.
GILCHRIST A.M., LEVINE M.S., CARR R.F., SAUL S.H., KATZKA D.A., HERLINGER H., laufer I. - Barrett’s esophagus-diagnosis by double contrast esophagography.Am. J. Roentgenoi, 1988,150, 97–102.
GILLISON E.W., DE CASTRO V.A.M., NYHUS L.M., KUSAKARI K., BOMBECK C.T. - The significance of bile in reflux esophagitis.Surgery Gynecol. Obstet., 1972,134, 419–424.
GOLDMAN M.C., BECKMAN R.C. - Barrett syndrome: case report with discussion about concepts of a pathogenesis.Gastroenterology, 1960,39, 104–110.
GORE S., SUTTON R., EYRE-BROOK I.A. et al. - Regression of columnar epithelium in Barrett’s esophagus with omeprazole. Gut, 1990,31, A 1191 (abstract).
Gruppo Operativo per lo Studio delle Precancerosi dell’ Esofago (GOSPE): Barrett’s esophagus : epidemiological and clinical results of a multicentric survey.Int. J. Cancer., 1991,48, 364–368.
HALVORSEN J.F., SENIB B.K.H. - The Barrett syndrome: an acquired condition secondary to reflux esophagitis.Acta Chir. Scand., 1975,141, 683–687.
HERLIHY K.J., ORLANDO R.C, BRYSON C, BOZYMSKL E.M., CARNEY C.N., POWELL D.W. - Barrett’s esophagus: clinical, endoscopic, histologie, mano- metric and electrical potential difference characteristics.Gastroenterology, 1984,86, 436–443.
HOWARD P.J., MAHER J., PRYDE A., HEADING R.C. - Symptomatic gastroesophageal reflux, abnormal acid exposure and mucosal acid sensitivity are three separated, though related, aspects of gastroesophageal reflux disease.Gut, 1991,32, 128–132.
JOHNSSON F., JOELSSON B., GUDMUNDSSON K., GREIFF L. - Symptoms and endoscopic findings in the gastroesophageal reflux disease.Scand. J. Gastroenterol, 1987,22, 714–718.
KAHRILAS P.J., DODDS W.J., HOGAN W.J., KERN M., ARNDORFER R.C., REECE A. - Esophageal peristaltic dysfunction in peptic esophagitis.Gastroenterology, 1986,91, 897–904.
KORTAN P., WARREN R.E., GARDNER J., GINSBERG R.J., DIAMANT N.E. -Barretts esophagus in a patient with surgically treated achalasia.J. Clin. Gastroenterol., 1981,3, 357–360.
MADDERN G.J., CHATTERTON BE., COLLINS P.J., HOROWITZ M., SHEARMAN D.J.C., JAMIESON G.G. - Solid and liquid gastric emptying in patients with gastroesophageal reflux. British journal of surgery. 1985,72, 344–347.
MANN N.S., TSAI M.F., NAIR P.K. - Barrett’s esophagus in patients with symptomatic reflux esophagitis.Am. J. Gastroenterol., 1989,84, 1494–1496.
MCCALLUM R.W., BERKOWITZ D.M., LERNER E. - Gastric emptying in patients with gastroesophageal reflux.Gastroenterology, 1981,80, 285–291.
MOSSBERG S.M. - The columnar-lined esophagus (Barrett syndrome): an acquired condition?Gastroenterology, 1966,50, 671–676.
NAEF A.P., SAVARY M., OZZELLO L. - Columnarlined lower esophagus: an acquired lesion with malignant predisposition.J. Thorac. Cardiovasc. Surg., 1975,70, 826–835.
NEBEL O.T., FORNES M.F., CASTELL D.O. - Symptomatic gastroesophageal reflux: incidence and precipitating factors.Am. J. Dig. Dis. Sci., 1976,21, 953–956.
ORTIZ ESCANDELL A., MARTINEZ DE HARO L.F., PARILLA PARFCIO P., MOLINA MARTINEZ J., AGUAYO ALBASINI J.L., MARTINEZ GOMEZ D. - Quantification of Gastroesophageal reflux in Barrett’s esophagus.Rev. Esp. Enferm. Dig., 1990,77, 171–175.
OVASKA J., MIETTINEN M.. KIVILAAKSO E. - Adenocarcinoma arising in Barrett’s esophagus.Dig. Dis. Sci., 1989,34, 1336–1339.
PACE F., SANTALUCIA F., BIANCHI PORRO G. - Natural history of gastroesophageal reflux disease without oesophagitis.Gut, 1991,32, 854–858.
PALMER E.D. - The hiatus hernia-esophagitis-esopha- geal stricture complex. Twenty-year prospective study.Am. J. Med., 1968,44, 566–579.
PATEL G.K., CLIFF S.A., READ R.C. - Mechanism of gastroesophageal reflux (GER) in patients with Barrett’s esophagus (abstract).Gastroenterology, 1982,82, 1146.
PHILLIPS R.W., WONG R.K. - Barrett’s esophagus. Natural history, incidence, etiology, and complications.Gastroenterol. Clin. North. Am., 1991,20, 791–816.
PUJIOL P., TOSSO H., RAVENBAKHT M., BRULEY DES VARANNES S., CLOAREC D., GALMICHE J.P. - Acid gastroesophageal reflux in Barrett’s esophagus.Z. Gastroenterol., 1989,27, 50–53.
ROTHERY G.A., PATTERSON J.E., STODARD C.J., DAY D.W. - Histological and histochemical changes in the columnar-lined (Barrett’s) oesophagus.Gut, 1986,27, 1062–1068.
SAMPLINER R. - Antireflux surgery and Barrett’s esophagus regression: Wheel of fortune, or to tell the truth?Am. J. Gastroenterol., 1991,86, 645–646.
SARR M.G., HAMILTON S.R., MARRONE G.C., CAMERON J.L. - Barrett’s esophagus: its prevalence and association with adenocarcioma in patients with symptoms of gastroesophageal reflux.Am. J. Surg., 1985,149, 187–193.
SCHNELL TV., SONTAG S.J., MILLER T., CHEJFEC G., KURUCAR C, OCONNELL S.- Are there indentifiable risk factors for the presence of Barrett’s esophagus in patients with gastroesophageal reflux?Gastroenterology, 1991,100, A156 (abstract).
SCHWEITZER E.J., HARMON J.W., BASSBLAND BATZRI S. - Bile acid reflux precedes mucosal barrier disruption in the rabbit esophagus.Am. J. Physiol., 1984,247, G480.
STARNES VA., ADKINS R.B., BALLINGER J.F., SAWYERS J.L. - Barrett’s esophagus: a surgical entity.Arch. Surg., 1984,119, 563–567.
SYMONDS DA., RAMSEY H.E. - Adenocarcinoma arising in Barrett’s esophagus with Zollinger Ellison syndrome.Am. J. din. Pathol., 1980,73, 823–826.
WARING J.P., LEGRAND J., CHINICHIAN A., SANOWSKI R.A. - Duodenogastric reflux in patients with Barrett’s esophagus.Dig. Dis. Sci., 1990,35, 759–762.
WESDORP I.C., BARTELSMAN J., SCHIPPER M.E.I., TYTGAT G.N.- Effect of long term treatment with cimetidine and antacids in Barrett’s esophagus.Gut, 1981,22, 724–727.
WILLIAMSON W.A., ELLIS F.H. Jr., GIBB S.P., SHAHIAN D.M., ARETZ HT. - Effect of antireflux operation on Barrett’s mucosa.Ann. Thorac. Surg., 1990,49, 537–542.
WINTERS C. Jr., SPURLING T.J., CHOBANIAN S.J., CURTIS D.J., ESPOSITO R.L., HACKER J.F. 3rd, JOHNSON D.A., CRUESS D.F., COTELINGAM J.D., GURNEY M.S. et al. - Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease.Gastroenterology, 1987,92, 118–124.
Author information
Authors and Affiliations
About this article
Cite this article
Fracasso, P., Stigliano, V. & Crespi, M. Relations entre œsophagite et endobrachyœsophage. Acta Endosc 22, 461–466 (1992). https://doi.org/10.1007/BF02965108
Issue Date:
DOI: https://doi.org/10.1007/BF02965108